Skip to content

Clinical trials

Completed Phase 2 Philadelphia Chromosome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Philadelphia Chromosome Phase: Phase 2 Status: Completed Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20041
20051
20061
20091
20111
20151
20171
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Assistance Publique - Hôpitaux de Paris1
Goethe University1
Institute of Hematology & Blood Diseases Hospital, China1
Japan Adult Leukemia Study Group1
Norwegian University of Science and Technology1
Pfizer1
Rennes University Hospital1
The First Affiliated Hospital of Soochow University1
University of Bologna1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Philadelphia Chromosome13
Precursor Cell Lymphoblastic Leukemia-Lymphoma9
Leukemia, Myelogenous, Chronic, BCR-ABL Positive8
Leukemia3
Leukemia, Myeloid, Acute3
Blast Crisis2
Leukemia, Biphenotypic, Acute1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.